New possibilities of chemotherapy for anthracyclineand/or taxane-resistant breast cancer

New possibilities of chemotherapy for anthracyclineand/or taxane-resistant breast cancer

Patients with metastatic breast cancer previously treated with anthracycline chemotherapy. Effective treatment options for patients with metastatic breast cancer resistant to anthracyclines and taxanes are limited. The review is devoted to chemotherapy-pretreated metastatic breast cancer, reasons of...

Full description

Bibliographic Details
Main Authors:	E V Artamonova, L V Manzyuk
Format:	Article
Language:	Russian
Published:	IP Habib O.N. 2013-06-01
Series:	Современная онкология
Subjects:	anthracycline- and/or taxane-resistance breast cancer ixabepilone
Online Access:	https://modernonco.orscience.ru/1815-1434/article/view/26889

Similar Items

Pharmacoeconomic characteristics of ixabepilone (Ixempra) monotherapy in patients with locally advanced and metastatic breast cancer resistant to treatment with anthracyclines, taxanes and capecitabin
by: A S Kolbin, et al.
Published: (2017-01-01)

Cost-effectiveness analysis of ixabepilone use in monotherapy in patients with locally advanced and metastatic breast cancer resistant to treatment with anthracyclines, taxanes and capecitabin
by: A S Kolbin, et al.
Published: (2018-03-01)

Effects of adding taxane to anthracycline-based neoadjuvant chemotherapy in locally advanced breast cancer
by: Azra Rašić, et al.
Published: (2019-02-01)

Sequential vs concurrent adjuvant chemotherapy of anthracycline and taxane for operable breast cancer
by: Wanjing Chen, et al.
Published: (2021-02-01)

ERCC1 Is a Predictor of Anthracycline Resistance and Taxane Sensitivity in Early Stage or Locally Advanced Breast Cancers
by: Tarek M. A. Abdel-Fatah, et al.
Published: (2019-08-01)

Oral vinorelbine: its role in advanced breast cancer pre-treated with anthracycline and taxane chemotherapies
by: Fausto Petrelli, et al.
Published: (2011-12-01)

Assessment of pulmonary toxicities in breast cancer patients undergoing treatment with anthracycline and taxane based chemotherapy and radiotherapy- a prospective study
by: Aramita Saha, et al.
Published: (2013-12-01)

Experience of eribulin application in previously treated patients with metastatic or locally recurrent breast cancer under the clinical trial
by: F Sh Ahmetzanov, et al.
Published: (2014-09-01)

Neoadjuvant chemotherapy regimens in treatment of breast cancer: a systematic review and network meta-analysis protocol
by: Mona Pathak, et al.
Published: (2018-06-01)

Prediction of therapeutic response to paclitaxel, docetaxel and ixabepilone in breast cancer
by: Kadra, Gais
Published: (2011)

Eribulin for the treatment of anthracyclineand taxane-resistant breast cancer: a big step forward towards problem solving
by: E V Artamonova
Published: (2017-09-01)

Mechanisms of Taxane Resistance
by: Sara M. Maloney, et al.
Published: (2020-11-01)

Weekly taxane–anthracycline combination regimen versus tri-weekly anthracycline-based regimen for the treatment of locally advanced breast cancer: a randomized controlled trial
by: Qiu-Wen Tan, et al.
Published: (2017-03-01)

Four Cycles of Docetaxel-Cyclophosphamide versus Anthracycline-Taxane as Adjuvant Chemotherapy for HER2-Negative, Axillary Lymph Node Negative Breast Cancer: A Real-World Comparison of Alberta Patients Treated 2008–2012
by: Malek Hannouf, et al.
Published: (2021-03-01)

Genetic polymorphisms of autophagy-related gene 5 (ATG5) rs473543 predict different disease-free survivals of triple-negative breast cancer patients receiving anthracycline- and/or taxane-based adjuvant chemotherapy
by: Meiying Li, et al.
Published: (2018-01-01)

Taxane-based adjuvant chemotherapy in node positive, early stage Turkish breast cancer patients
by: Alacacioglu Ahmet, et al.
Published: (2009-12-01)

Combination of Ixabepilone and Capecitabine in Metastatic Triple Negative Breast Cancer. Clinical case
by: E. V. Glazkova, et al.
Published: (2019-12-01)

Reliability and Validity of the Turkish Version of Chemotherapy-induced Peripheral Neuropathy Assessment Tool for Breast Cancer Patients Receiving Taxane Chemotherapy
by: Neriman Yükseltürk Simsek, et al.
Published: (2018-01-01)

Cognitive Effects and Depression Associated With Taxane-Based Chemotherapy in Breast Cancer Survivors: A Meta-Analysis
by: Eiman Y. Ibrahim, et al.
Published: (2021-04-01)

TAXANES IN THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER
by: T. N. Skvortsova, et al.
Published: (2017-01-01)

Synthetic approaches to taxanes
by: Berry, N. M.
Published: (1987)

Practical consensus recommendations for neo-adjuvant chemotherapy in triple negative breast cancer
by: G S Bhattacharyya, et al.
Published: (2018-01-01)

Ixabepilone: new perspectives for its use in breast cancer
by: A. A. Mescheryakov, et al.
Published: (2018-11-01)

Development of cytotoxic chemotherapy in metastatic breast cancer with a triple-negative phenotype
by: E V Karabina, et al.
Published: (2016-06-01)

Taxanes in adjuvant and neoadjuvant therapy for breast cancer
by: S. V. Limareva
Published: (2014-08-01)

Cisplatin & IV Etoposide combination in the treatment of advanced breast cancer pretreated with anthracyclines
by: Anmar Allami
Published: (2019-06-01)

Microtubule Destabilizing Sulfonamides as An Alternative to Taxane-Based Chemotherapy
by: Myriam González, et al.
Published: (2021-02-01)

Practical consensus recommendations for gestational breast cancer
by: J S Sekhon, et al.
Published: (2018-01-01)

Taxane-Induced Upper Gastrointestinal Bleeding
by: Yao Liu, et al.
Published: (2021-09-01)

Taxane therapy in the adjuvant treatment of breast cancer in Italy: economic evaluation
by: Simona Ravera, et al.
Published: (2006-03-01)

Oxidative Stress and Cognitive Alterations Induced by Cancer Chemotherapy Drugs: A Scoping Review
by: Omar Cauli
Published: (2021-07-01)

Albumin-bound paclitaxel in the treatment of metastatic breast cancer
by: E V Artamonova
Published: (2017-01-01)

A Prospective Study of Taxane-Induced Neuropathy with Breast Cancer: Proper Assessment Tool for Taxane-Induced Neuropathy
by: Eun Hee Sohn, et al.
Published: (2021-04-01)

Patient Preferences Regarding Chemotherapy in Metastatic Breast Cancer—A Conjoint Analysis for Common Taxanes
by: Saskia Spaich, et al.
Published: (2018-11-01)

Primary Squamous Cell Carcinoma of Breast Responsive to Platinum and Taxane-Based Chemotherapy: A Rare Entity and Review Literature
by: Jagjit K. Pandey, et al.
Published: (2020-07-01)

Impact of Taxanes, Endocrine Therapy, and Deleterious Germline BRCA Mutations on Anti-müllerian Hormone Levels in Early Breast Cancer Patients Treated With Anthracycline- and Cyclophosphamide-Based Chemotherapy
by: Matteo Lambertini, et al.
Published: (2019-07-01)

CLINICAL ASSESSMENT OF TAXANES IN THE FIRST-LINE CYTOTOXIC THERAPY OF CASTRATION-RESISTANT PROSTATE CANCER
by: A. A. GRITSKEVICH, et al.
Published: (2016-12-01)

Synthesis amongst taxanes
by: Harrison, A. G.
Published: (1986)

Beau’s Lines Resulting from Taxane Chemotherapy
by: Kumpol Aiempanakit
Published: (2018-10-01)

Novel Combinations for the Treatment of Metastatic Breast Cancer
by: Linda T. Vahdat
Published: (2010-01-01)